Cargando…
Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies
Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Interim results from five European studies indicate that, in all age groups, 2017/18 influenza vaccine effectiveness was 25...
Autores principales: | Rondy, Marc, Kissling, Esther, Emborg, Hanne-Dorthe, Gherasim, Alin, Pebody, Richard, Trebbien, Ramona, Pozo, Francisco, Larrauri, Amparo, McMenamin, Jim, Valenciano, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840921/ https://www.ncbi.nlm.nih.gov/pubmed/29510782 http://dx.doi.org/10.2807/1560-7917.ES.2018.23.9.18-00086 |
Ejemplares similares
-
Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019
por: Kissling, Esther, et al.
Publicado: (2019) -
Interim 2019/20 influenza vaccine effectiveness: six European studies, September 2019 to January 2020
por: Rose, Angela, et al.
Publicado: (2020) -
A late sharp increase in influenza detections and low interim vaccine effectiveness against the circulating A(H3N2) strain, Denmark, 2021/22 influenza season up to 25 March 2022
por: Emborg, Hanne-Dorthe, et al.
Publicado: (2022) -
Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season
por: Rondy, Marc, et al.
Publicado: (2017) -
Early and intense epidemic of respiratory syncytial virus (RSV) in Denmark, August to December 2022
por: Munkstrup, Charlotte, et al.
Publicado: (2023)